SCFSkp2-IN-2
CAS No. 1375060-02-8
SCFSkp2-IN-2 ( —— )
产品货号. M36410 CAS No. 1375060-02-8
SCFSkp2-IN-2 (Compound AAA-237) 是一种 Skp2 抑制剂,其 KD 为 28.77 μM。AAA-237 诱导 NSCLC 细胞凋亡 (apoptosis),显示出抗肿瘤活性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥315 | 有现货 |
|
| 10MG | ¥517 | 有现货 |
|
| 25MG | ¥1001 | 有现货 |
|
| 50MG | ¥1666 | 有现货 |
|
| 100MG | ¥2846 | 有现货 |
|
| 500MG | ¥6648 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称SCFSkp2-IN-2
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述SCFSkp2-IN-2 (Compound AAA-237) 是一种 Skp2 抑制剂,其 KD 为 28.77 μM。AAA-237 诱导 NSCLC 细胞凋亡 (apoptosis),显示出抗肿瘤活性。
-
产品描述SCFSkp2-IN-2 (Compound AAA-237) is a Skp2 inhibitor with a KD of 28.77 μM. AAA-237 induces apoptosis of NSCLC cells and shows antitumor activities.
-
体外实验Western Blot AnalysisCell Line:A549 and H1299 cellsConcentration:0.3, 1 and 3 μMIncubation Time:24, 48 and 72 hResult: Increased the expression levels of p21Cip1 and p27Kip1. Decreased the level of Skp2. Reduced the expression levels of CDK2, p-CDK2, cyclin E1, CDK4, p-CDK4 and cyclin D. Increased the levels of cleaved PARP, cleaved caspase 3, cleaved caspase 9 and Bax. Decreased the expression of PARP and Bcl-2.Cell Proliferation Assay Cell Line:A549 and H1299 cells Concentration:0.3, 1 and 3 μM Incubation Time:24, 48 and 72 h Result:Inhibited the proliferation of A549 and H1299 cells in a dose- and time-dependent manner. The IC50 for A549 was 3?μM at 24?h, 2.5?μM at 48?h and 0.7?μM at 72?h. The IC50 for H1299 was 3.9?μM at 24?h, 1.8?μM at 48?h and 1.1?μM at 72?h.Cell Cycle Analysis Cell Line:A549 and H1299 cells Concentration:0.3, 1 and 3 μM Incubation Time:24, 48 and 72 h Result: Arrested the cell cycle at G0/G1 in a dose- and time-dependent manner. Apoptosis Analysis Cell Line:A549 and H1299 cells Concentration:0.3, 1 and 3 μM Incubation Time:24, 48 and 72 h Result:The ratio of JC-1 monomer/JC-1 polymer was increased in A549 and H1299 cells as the concentration was increased.
-
体内实验Animal Model:A549 xenograft model Dosage:15 or 45?mg/kg Administration:Intraperitoneal administration, daily for 14 days Result:Significantly reduced tumor volume and weight. The tumor growth inhibition of the low dose and high dose was 55% and 64%, respectively. No obvious weight loss or abnormal behavior was observed. Reduced the expression of Ki67 in tumor tissue. Reduced the expression of Skp2 and Bcl-2 and increased the expression of p27, the cleaving of caspase 3, caspase 9, PARP and Bax.
-
同义词——
-
通路Apoptosis
-
靶点Apoptosis
-
受体Apoptosis | E1/E2/E3 Enzyme
-
研究领域——
-
适应症——
化学信息
-
CAS Number1375060-02-8
-
分子量312.37
-
分子式C17H20N4O2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 125 mg/mL (400.17 mM; 超声助溶 (<60°C)
-
SMILESN(CC)(CC)C1=CC(O)=C(/C=N/NC(=O)C=2C=CC=NC2)C=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Liu J, et al. Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence. Pharmacol Res. 2022 Jul;181:106259.?
产品手册
关联产品
-
Kinsenoside;(+)-Kins...
Kinsenoside 显示出显着的抗肝毒性和抗炎活性。金参皂苷可用于修复胰岛损伤的β细胞并改善其功能,它可以促进糖尿病和正常健康大鼠急性血糖升高的糖耐量。
-
CCT128930 hydrochlor...
CCT128930 盐酸盐是一种有效的选择性 AKT 抑制剂,IC50 为 6 nM。 CCT128930 盐酸盐诱导细胞周期停滞、DNA 损伤和自噬。
-
ZNL 02-096
Pomalidomide-C3-adavosertib 是一种快速和选择性的 Wee1 降解剂 (IC50=3.58 nM)。Pomalidomide-C3-adavosertib 具有抗癌细胞增殖活性,并能诱导细胞凋亡。
021-51111890
购物车()
sales@molnova.cn

